These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
183 related articles for article (PubMed ID: 20352109)
1. Association of the CTLA4 gene with Graves' disease in the Chinese Han population. Zhao SX; Pan CM; Cao HM; Han B; Shi JY; Liang J; Gao GQ; Peng YD; Su Q; Chen JL; Zhao JJ; Song HD PLoS One; 2010 Mar; 5(3):e9821. PubMed ID: 20352109 [TBL] [Abstract][Full Text] [Related]
2. Correlation between CTLA-4 and CD40 gene polymorphisms and their interaction in graves' disease in a Chinese Han population. Chen X; Hu Z; Liu M; Li H; Liang C; Li W; Bao L; Chen M; Wu G BMC Med Genet; 2018 Sep; 19(1):171. PubMed ID: 30223781 [TBL] [Abstract][Full Text] [Related]
3. A significant association of the CTLA4 gene variants with the risk of autoimmune Graves' disease in ethnic Kashmiri population. Shehjar F; Dil-Afroze ; Misgar RA; Malik SA; Laway BA Cell Immunol; 2020 Jan; 347():103995. PubMed ID: 31708111 [TBL] [Abstract][Full Text] [Related]
4. Influence of the TSH receptor gene on susceptibility to Graves' disease and Graves' ophthalmopathy. Yin X; Latif R; Bahn R; Tomer Y; Davies TF Thyroid; 2008 Nov; 18(11):1201-6. PubMed ID: 18925838 [TBL] [Abstract][Full Text] [Related]
5. Genetic heterogeneity of susceptibility gene in different ethnic populations: refining association study of PTPN22 for Graves' disease in a Chinese Han population. Xue L; Pan C; Gu Z; Zhao S; Han B; Liu W; Yang S; Yu S; Sun Y; Liang J; Gao G; Zhang X; Yuan G; Li C; Du W; Chen G; Chen J; Song H PLoS One; 2013; 8(12):e84514. PubMed ID: 24386393 [TBL] [Abstract][Full Text] [Related]
6. Family-based association study of cytotoxic T-lymphocyte antigen-4 with susceptibility to Graves' disease in Han population of Taiwan. Chen PL; Fann CS; Chang CC; Wu IL; Chiu WY; Lin CY; Yang WS; Chang TC Genes Immun; 2008 Mar; 9(2):87-92. PubMed ID: 18059468 [TBL] [Abstract][Full Text] [Related]
7. The common -318C/T polymorphism in the promoter region of CTLA4 gene is associated with reduced risk of ophthalmopathy in Chinese Graves' patients. Han SZ; Zhang SH; Li R; Zhang WY; Li Y Int J Immunogenet; 2006 Aug; 33(4):281-7. PubMed ID: 16893393 [TBL] [Abstract][Full Text] [Related]
8. CT60 single nucleotide polymorphism of the CTLA-4 gene is associated with susceptibility to Graves' disease in the Taiwanese population. Weng YC; Wu MJ; Lin WS Ann Clin Lab Sci; 2005; 35(3):259-64. PubMed ID: 16081581 [TBL] [Abstract][Full Text] [Related]
9. HLA and CTLA4 polymorphisms may confer a synergistic risk in the susceptibility to Graves' disease. Takahashi M; Kimura A J Hum Genet; 2010 May; 55(5):323-6. PubMed ID: 20300120 [TBL] [Abstract][Full Text] [Related]
10. Association of Cytotoxic T-Lymphocyte-Associated Protein 4 (CTLA4) Gene Polymorphisms with Autoimmune Thyroid Disease in Children and Adults: Case-Control Study. Ting WH; Chien MN; Lo FS; Wang CH; Huang CY; Lin CL; Lin WS; Chang TY; Yang HW; Chen WF; Lien YP; Cheng BW; Lin CH; Chen CC; Wu YL; Hung CM; Li HJ; Chan CI; Lee YJ PLoS One; 2016; 11(4):e0154394. PubMed ID: 27111218 [TBL] [Abstract][Full Text] [Related]
11. Association of CTLA-4 and IL-13 gene polymorphisms with Graves' disease and ophthalmopathy in Chinese children. Chong KK; Chiang SW; Wong GW; Tam PO; Ng TK; Hu YJ; Yam GH; Lam DS; Pang CP Invest Ophthalmol Vis Sci; 2008 Jun; 49(6):2409-15. PubMed ID: 18296657 [TBL] [Abstract][Full Text] [Related]
12. Clinical associations of the genetic variants of CTLA-4, Tg, TSHR, PTPN22, PTPN12 and FCRL3 in patients with Graves' disease. Gu LQ; Zhu W; Zhao SX; Zhao L; Zhang MJ; Cui B; Song HD; Ning G; Zhao YJ Clin Endocrinol (Oxf); 2010 Feb; 72(2):248-55. PubMed ID: 19438904 [TBL] [Abstract][Full Text] [Related]
13. Genetic Study in a Large Cohort Supported Different Pathogenesis of Graves' Disease and Hashimoto's Hypothyroidism. Zhang QY; Liu W; Li L; Du WH; Zuo CL; Ye XP; Zhou Z; Yuan FF; Ma YR; Sun F; Yu SS; Xie HJ; Zhang CR; Ying YX; Yuan GY; Gao GQ; Liang J; Zhao SX; Song HD J Clin Endocrinol Metab; 2020 Jul; 105(7):. PubMed ID: 32246145 [TBL] [Abstract][Full Text] [Related]
14. Zhang M; Liu S; Xu J; Lv S; Fan Y; Zhang Y; Zhang Y; Wu Y; Su Y; Yu H; Song S; He J; Li H Curr Eye Res; 2020 Jul; 45(7):888-895. PubMed ID: 31869260 [TBL] [Abstract][Full Text] [Related]
15. Association of cytotoxic T-lymphocyte-associated antigen-4 (CTLA-4) gene polymorphism and non-genetic factors with Graves' ophthalmopathy in European and Japanese populations. Bednarczuk T; Hiromatsu Y; Fukutani T; Jazdzewski K; Miskiewicz P; Osikowska M; Nauman J Eur J Endocrinol; 2003 Jan; 148(1):13-8. PubMed ID: 12534352 [TBL] [Abstract][Full Text] [Related]
16. CTLA4 gene and Graves' disease: association of Graves' disease with the CTLA4 exon 1 and intron 1 polymorphisms, but not with the promoter polymorphism. Vaidya B; Oakes EJ; Imrie H; Dickinson AJ; Perros P; Kendall-Taylor P; Pearce SH Clin Endocrinol (Oxf); 2003 Jun; 58(6):732-5. PubMed ID: 12780750 [TBL] [Abstract][Full Text] [Related]
17. CTLA4 polymorphisms and ophthalmopathy in Graves' disease patients: association study and meta-analysis. Han S; Zhang S; Zhang W; Li R; Li Y; Wang Z; Xie Y; Mao Y Hum Immunol; 2006 Aug; 67(8):618-26. PubMed ID: 16916658 [TBL] [Abstract][Full Text] [Related]
18. Synergistic combined effect between CD40-1C>T and CTLA-4+6230G>A polymorphisms in Graves' disease. Chen X; Hu Z; Li W; Wu P; Liu M; Bao L; Wu M; Fang S; Xiong W; Chen M; Wu G Gene; 2015 Aug; 567(2):154-8. PubMed ID: 25936345 [TBL] [Abstract][Full Text] [Related]
19. Association of the T-cell regulatory gene CTLA4 with Graves' disease and autoimmune thyroid disease in the Japanese. Furugaki K; Shirasawa S; Ishikawa N; Ito K; Ito K; Kubota S; Kuma K; Tamai H; Akamizu T; Hiratani H; Tanaka M; Sasazuki T J Hum Genet; 2004; 49(3):166-168. PubMed ID: 14986169 [TBL] [Abstract][Full Text] [Related]
20. CTLA4 gene polymorphism confers susceptibility to Graves' disease in Japanese. Yanagawa T; Taniyama M; Enomoto S; Gomi K; Maruyama H; Ban Y; Saruta T Thyroid; 1997 Dec; 7(6):843-6. PubMed ID: 9459626 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]